Cargando…

Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer

PURPOSE: The efficacy of immunotherapy for non-small cell lung cancer (NSCLC) is limited owing to cold tumors and drug resistance. Therefore, it is important to identify the molecular mechanisms underlying immune evasion in NSCLC. Spontaneous ferroptosis of neutrophils has been suggested as a key me...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuandi, Xing, Lijuan, Deng, Lexiu, Wang, Xinsheng, Xu, Dandan, Wang, Bu, Zhang, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039630/
https://www.ncbi.nlm.nih.gov/pubmed/36974063
http://dx.doi.org/10.2147/IJGM.S401225
_version_ 1784912309637873664
author Wang, Yuandi
Xing, Lijuan
Deng, Lexiu
Wang, Xinsheng
Xu, Dandan
Wang, Bu
Zhang, Zhihua
author_facet Wang, Yuandi
Xing, Lijuan
Deng, Lexiu
Wang, Xinsheng
Xu, Dandan
Wang, Bu
Zhang, Zhihua
author_sort Wang, Yuandi
collection PubMed
description PURPOSE: The efficacy of immunotherapy for non-small cell lung cancer (NSCLC) is limited owing to cold tumors and drug resistance. Therefore, it is important to identify the molecular mechanisms underlying immune evasion in NSCLC. Spontaneous ferroptosis of neutrophils has been suggested as a key mechanism of immunosuppression in cancer. Insulin-like growth factor binding protein 1 (IGFBP1) plays an important role in immune infiltration in several cancers. However, the role of IGFBP1 in NSCLC is unknown. Therefore, in this study, we aimed to investigate the association of IGFBP1 mRNA expression with infiltration of myeloid-derived suppressor cells and prognosis in NSCLC. PATIENTS AND METHODS: Retrospective RNA-seq data from 990 patients in the Cancer Genome Atlas (TCGA) database were analyzed in relation to patient clinical characteristics. The Timer2 database was used to assess immune infiltration, and the FerrDb V2 database was used to obtain ferroptosis-related genes. Finally, the results were validated by the proteomic analysis of serum samples collected from six patients with NSCLC and six healthy individuals. RESULTS: IGFBP1 expression was enriched in lung adenocarcinoma samples and positively correlated with the pathological grade of NSCLC. IGFBP1 expression was an independent prognostic factor for the overall survival of patients with NSCLC. In addition, IGFBP1 expression correlated with myeloid-derived suppressor cell infiltration. Notably, Gene Ontology analysis of IGFBP1-related genes revealed that the major molecular functions of their protein products were related to NADP(+) 1-oxidoreductase activity. Furthermore, expression levels of multiple ferroptosis suppressor genes positively correlated with IGFBP1 expression. CONCLUSION: High IGFBP1 expression indicates a poor prognosis in patients with NSCLC, which may be related to tumor immunosuppression caused by neutrophil ferroptosis.
format Online
Article
Text
id pubmed-10039630
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100396302023-03-26 Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer Wang, Yuandi Xing, Lijuan Deng, Lexiu Wang, Xinsheng Xu, Dandan Wang, Bu Zhang, Zhihua Int J Gen Med Original Research PURPOSE: The efficacy of immunotherapy for non-small cell lung cancer (NSCLC) is limited owing to cold tumors and drug resistance. Therefore, it is important to identify the molecular mechanisms underlying immune evasion in NSCLC. Spontaneous ferroptosis of neutrophils has been suggested as a key mechanism of immunosuppression in cancer. Insulin-like growth factor binding protein 1 (IGFBP1) plays an important role in immune infiltration in several cancers. However, the role of IGFBP1 in NSCLC is unknown. Therefore, in this study, we aimed to investigate the association of IGFBP1 mRNA expression with infiltration of myeloid-derived suppressor cells and prognosis in NSCLC. PATIENTS AND METHODS: Retrospective RNA-seq data from 990 patients in the Cancer Genome Atlas (TCGA) database were analyzed in relation to patient clinical characteristics. The Timer2 database was used to assess immune infiltration, and the FerrDb V2 database was used to obtain ferroptosis-related genes. Finally, the results were validated by the proteomic analysis of serum samples collected from six patients with NSCLC and six healthy individuals. RESULTS: IGFBP1 expression was enriched in lung adenocarcinoma samples and positively correlated with the pathological grade of NSCLC. IGFBP1 expression was an independent prognostic factor for the overall survival of patients with NSCLC. In addition, IGFBP1 expression correlated with myeloid-derived suppressor cell infiltration. Notably, Gene Ontology analysis of IGFBP1-related genes revealed that the major molecular functions of their protein products were related to NADP(+) 1-oxidoreductase activity. Furthermore, expression levels of multiple ferroptosis suppressor genes positively correlated with IGFBP1 expression. CONCLUSION: High IGFBP1 expression indicates a poor prognosis in patients with NSCLC, which may be related to tumor immunosuppression caused by neutrophil ferroptosis. Dove 2023-03-21 /pmc/articles/PMC10039630/ /pubmed/36974063 http://dx.doi.org/10.2147/IJGM.S401225 Text en © 2023 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Yuandi
Xing, Lijuan
Deng, Lexiu
Wang, Xinsheng
Xu, Dandan
Wang, Bu
Zhang, Zhihua
Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer
title Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer
title_full Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer
title_fullStr Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer
title_full_unstemmed Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer
title_short Clinical Characterization of the Expression of Insulin-Like Growth Factor Binding Protein 1 and Tumor Immunosuppression Caused by Ferroptosis of Neutrophils in Non-Small Cell Lung Cancer
title_sort clinical characterization of the expression of insulin-like growth factor binding protein 1 and tumor immunosuppression caused by ferroptosis of neutrophils in non-small cell lung cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039630/
https://www.ncbi.nlm.nih.gov/pubmed/36974063
http://dx.doi.org/10.2147/IJGM.S401225
work_keys_str_mv AT wangyuandi clinicalcharacterizationoftheexpressionofinsulinlikegrowthfactorbindingprotein1andtumorimmunosuppressioncausedbyferroptosisofneutrophilsinnonsmallcelllungcancer
AT xinglijuan clinicalcharacterizationoftheexpressionofinsulinlikegrowthfactorbindingprotein1andtumorimmunosuppressioncausedbyferroptosisofneutrophilsinnonsmallcelllungcancer
AT denglexiu clinicalcharacterizationoftheexpressionofinsulinlikegrowthfactorbindingprotein1andtumorimmunosuppressioncausedbyferroptosisofneutrophilsinnonsmallcelllungcancer
AT wangxinsheng clinicalcharacterizationoftheexpressionofinsulinlikegrowthfactorbindingprotein1andtumorimmunosuppressioncausedbyferroptosisofneutrophilsinnonsmallcelllungcancer
AT xudandan clinicalcharacterizationoftheexpressionofinsulinlikegrowthfactorbindingprotein1andtumorimmunosuppressioncausedbyferroptosisofneutrophilsinnonsmallcelllungcancer
AT wangbu clinicalcharacterizationoftheexpressionofinsulinlikegrowthfactorbindingprotein1andtumorimmunosuppressioncausedbyferroptosisofneutrophilsinnonsmallcelllungcancer
AT zhangzhihua clinicalcharacterizationoftheexpressionofinsulinlikegrowthfactorbindingprotein1andtumorimmunosuppressioncausedbyferroptosisofneutrophilsinnonsmallcelllungcancer